IRIDEX CORP Files 8-K Report

Ticker: IRIX · Form: 8-K · Filed: Sep 9, 2025 · CIK: 1006045

Iridex Corp 8-K Filing Summary
FieldDetail
CompanyIridex Corp (IRIX)
Form Type8-K
Filed DateSep 9, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01, $2,500,000
Sentimentneutral

Sentiment: neutral

Topics: 8-K, filing, exhibits

Related Tickers: IRIX

TL;DR

IRIDEX filed an 8-K, likely routine or exhibit-related. Watch for details.

AI Summary

On August 27, 2025, IRIDEX CORPORATION filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial transactions or material events were detailed in the provided excerpt, suggesting it may be a routine filing or related to exhibit submissions.

Why It Matters

This 8-K filing indicates IRIDEX CORPORATION is providing updates or submitting exhibits to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — The provided excerpt is a standard 8-K filing notification without specific material event disclosures, indicating low immediate risk.

Key Players & Entities

  • IRIDEX CORPORATION (company) — Registrant
  • August 27, 2025 (date) — Date of Report
  • 1212 Terra Bella Avenue Mountain View , California 94043 (address) — Principal executive offices

FAQ

What specific "Other Events" are being reported by IRIDEX CORPORATION in this 8-K filing?

The provided excerpt does not detail the specific "Other Events" being reported; it only lists the item information category.

What "Financial Statements and Exhibits" are being filed by IRIDEX CORPORATION?

The excerpt indicates that "Financial Statements and Exhibits" are part of the filing, but does not list the specific documents included.

What is the significance of the filing date August 27, 2025?

August 27, 2025, is the date of the earliest event reported in this 8-K filing.

What is IRIDEX CORPORATION's principal executive office address?

IRIDEX CORPORATION's principal executive office is located at 1212 Terra Bella Avenue, Mountain View, California 94043.

What is the SEC file number for IRIDEX CORPORATION?

The SEC file number for IRIDEX CORPORATION is 000-27598.

Filing Stats: 604 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2025-09-09 16:22:11

Key Financial Figures

  • $0.01 — ch Registered Common Stock, par value $0.01 per share IRIX Nasdaq Capital Marke
  • $2,500,000 — mum stockholders' equity requirement of $2,500,000 for continued listing on the Nasdaq Cap

Filing Documents

01. Other Events

Item 8.01. Other Events. As previously reported, on May 14, 2025, IRIDEX Corporation (the "Company") received a notification of non-compliance (the "Notice") from Nasdaq's Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, based upon its Quarterly Report on Form 10-Q for the quarterly period ended March 29, 2025 that was filed with the Securities and Exchange Commission (the "SEC") on May 13, 2025, the Company was not in compliance with the continued listing standards set forth in Nasdaq Listing Rule 5550(b). On August 27, 2025, the Company received written notice from Nasdaq informing the Company that, based upon its Quarterly Report on Form 10-Q for the quarterly period ended June 28, 2025 that was filed with the SEC on August 12, 2025, the Company has regained compliance with the continued listing standards of Nasdaq Listing Rule 5550(b) by satisfying the minimum stockholders' equity requirement of $2,500,000 for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(1) (the "Stockholders' Equity Requirement"), and that the matter is now closed. On September 9, 2025, the Company issued a press release regarding its regained compliance with the Stockholders' Equity Requirement. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated September 9, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). - 2 -

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IRIDEX CORPORATION By: /s/ PATRICK MERCER Patrick Mercer Chief Executive Officer Date: September 9, 2025 - 3 -

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.